2 most recent filings and news items mentioning RANI. Updated every 60 seconds.
LeadershipJun 29, 2026Positive
Rani Therapeutics LLC has issued an offer letter to Nicholas M. Maestas to serve as its new Chief Financial Officer, effective June 29, 2026. The hiring of a new CFO marks a significant leadership transition for the biotechnology company, potentially influencing its financial ove
View filing at SEC.gov →
OfferingMay 27, 2026Neutral
Rani Therapeutics Holdings filed warrant documentation allowing holders to purchase Class A Common Stock at a specified exercise price starting from the original issue date. The offering provides investors with equity participation rights in the biopharmaceutical company.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.